Get Real Time Here
| Open226.000 | Close208.320 |
| Vol / Avg.1.004M / 485.990K | Mkt Cap4.146B |
| Day Range194.884 - 227.940 | 52 Wk Range57.220 - 322.670 |
Madrigal Pharmaceuticals Stock (NASDAQ:MDGL), Quotes and News Summary
Madrigal Pharmaceuticals Stock (NASDAQ: MDGL) stock price, news, charts, stock research, profile.
| Open226.000 | Close208.320 |
| Vol / Avg.1.004M / 485.990K | Mkt Cap4.146B |
| Day Range194.884 - 227.940 | 52 Wk Range57.220 - 322.670 |
Earnings
see more| Q4 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -4.920 | -5.340 | -0.4200 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-11-14 | JMP Securities | Jonathan Wolleben | Reiterates | Market OutperformMarket Outperform | Maintains | - | 383.00 |
| 2023-11-13 | HC Wainwright & Co. | Ed Arce | Maintains | BuyBuy | Raises | 225.00 | 275.00 |
| 2023-09-19 | Evercore ISI Group | Liisa Bayko | Maintains | OutperformOutperform | Maintains | 325.00 | 325.00 |
| 2023-09-14 | HC Wainwright & Co. | Ed Arce | Reiterates | BuyBuy | Maintains | - | 225.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| MDGL | Madrigal Pharmaceuticals | -10.87% | 4.1B |
| IMVT | Immunovant | -2.68% | 5.7B |
| RARE | Ultragenyx Pharmaceutical | -2.32% | 3.3B |
| MLTX | MoonLake | 2.39% | 3.4B |
| KRTX | Karuna Therapeutics | -0.37% | 7.8B |
How do I buy Madrigal Pharmaceuticals (MDGL) stock?
You can purchase shares of Madrigal Pharmaceuticals (NASDAQ: MDGL) through any online brokerage.
Who are Madrigal Pharmaceuticals's (MDGL) competitors?
Other companies in Madrigal Pharmaceuticals’s space includes: Immunovant (NASDAQ:IMVT), Ultragenyx Pharmaceutical (NASDAQ:RARE), MoonLake (NASDAQ:MLTX), Karuna Therapeutics (NASDAQ:KRTX) and Ionis Pharmaceuticals (NASDAQ:IONS).
What is the target price for Madrigal Pharmaceuticals (MDGL) stock?
The latest price target for Madrigal Pharmaceuticals (NASDAQ: MDGL) was reported by JMP Securities on Tuesday, November 14, 2023. The analyst firm set a price target for 383.00 expecting MDGL to rise to within 12 months (a possible 82.38% upside). 21 analyst firms have reported ratings in the last year.
Current Stock Price for Madrigal Pharmaceuticals (MDGL)?
The stock price for Madrigal Pharmaceuticals (NASDAQ: MDGL) is $210 last updated December 9, 2023 at 12:20 AM UTC.
Does Madrigal Pharmaceuticals (MDGL) pay a dividend?
There is no dividend information for Madrigal Pharmaceuticals.
When is Madrigal Pharmaceuticals (NASDAQ:MDGL) reporting earnings?
Madrigal Pharmaceuticals’s Q4 earnings are confirmed for Thursday, February 22, 2024.
Is Madrigal Pharmaceuticals (MDGL) going to split?
There is no upcoming split for Madrigal Pharmaceuticals.
What sector and industry does Madrigal Pharmaceuticals (MDGL) operate in?
Madrigal Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.